AmerisourceBergen Valuation
| ABG Stock | EUR 232.05 0.25 0.11% |
At this time, the firm appears to be fairly valued. AmerisourceBergen shows a prevailing Real Value of €223.84 per share. The current price of the firm is €232.05. Our model approximates the value of AmerisourceBergen from analyzing the firm fundamentals such as profit margin of 0.01 %, and Return On Equity of 0.5 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that AmerisourceBergen's price fluctuation is very steady at this time. Calculation of the real value of AmerisourceBergen is based on 3 months time horizon. Increasing AmerisourceBergen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the AmerisourceBergen stock is determined by what a typical buyer is willing to pay for full or partial control of AmerisourceBergen. Since AmerisourceBergen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AmerisourceBergen Stock. However, AmerisourceBergen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 232.05 | Real 223.84 | Hype 232.05 | Naive 234.67 |
The real value of AmerisourceBergen Stock, also known as its intrinsic value, is the underlying worth of AmerisourceBergen Company, which is reflected in its stock price. It is based on AmerisourceBergen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AmerisourceBergen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AmerisourceBergen helps investors to forecast how AmerisourceBergen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AmerisourceBergen more accurately as focusing exclusively on AmerisourceBergen's fundamentals will not take into account other important factors: AmerisourceBergen Total Value Analysis
AmerisourceBergen is presently estimated to have takeover price of 33.88 B with market capitalization of 29.69 B, debt of 4.63 B, and cash on hands of 2.88 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AmerisourceBergen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
33.88 B | 29.69 B | 4.63 B | 2.88 B |
AmerisourceBergen Investor Information
About 17.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.55. AmerisourceBergen recorded earning per share (EPS) of 7.77. The entity last dividend was issued on the 9th of February 2023. The firm had 2:1 split on the 16th of June 2009. Based on the analysis of AmerisourceBergen's profitability, liquidity, and operating efficiency, AmerisourceBergen is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.AmerisourceBergen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AmerisourceBergen has an asset utilization ratio of 421.83 percent. This implies that the Company is making €4.22 for each dollar of assets. An increasing asset utilization means that AmerisourceBergen is more efficient with each dollar of assets it utilizes for everyday operations.AmerisourceBergen Ownership Allocation
AmerisourceBergen holds a total of 202.26 Million outstanding shares. The majority of AmerisourceBergen outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AmerisourceBergen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AmerisourceBergen. Please pay attention to any change in the institutional holdings of AmerisourceBergen as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.AmerisourceBergen Profitability Analysis
The company reported the revenue of 238.59 B. Net Income was 1.7 B with profit before overhead, payroll, taxes, and interest of 8.33 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AmerisourceBergen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AmerisourceBergen and how it compares across the competition.
About AmerisourceBergen Valuation
The stock valuation mechanism determines AmerisourceBergen's current worth on a weekly basis. Our valuation model uses a comparative analysis of AmerisourceBergen. We calculate exposure to AmerisourceBergen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AmerisourceBergen's related companies.AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania. AMERISOURCEBERGEN operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21000 people.
8 Steps to conduct AmerisourceBergen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AmerisourceBergen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AmerisourceBergen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AmerisourceBergen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AmerisourceBergen's revenue streams: Identify AmerisourceBergen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AmerisourceBergen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AmerisourceBergen's growth potential: Evaluate AmerisourceBergen's management, business model, and growth potential.
- Determine AmerisourceBergen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AmerisourceBergen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AmerisourceBergen Stock analysis
When running AmerisourceBergen's price analysis, check to measure AmerisourceBergen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AmerisourceBergen is operating at the current time. Most of AmerisourceBergen's value examination focuses on studying past and present price action to predict the probability of AmerisourceBergen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AmerisourceBergen's price. Additionally, you may evaluate how the addition of AmerisourceBergen to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |